|
1
|
Garcia-Pavia P, Cobo-Marcos M,
Guzzo-Merello G, Gomez-Bueno M, Bornstein B, Lara-Pezzi E, Segovia
J and Alonso-Pulpon L: Genetics in dilated cardiomyopathy. Biomark
Med. 7:517–533. 2013. View Article : Google Scholar
|
|
2
|
Lakdawala NK, Winterfield JR and Funke BH:
Dilated cardiomyopathy. Circ Arrhythm Electrophysiol. 6:228–237.
2013. View Article : Google Scholar
|
|
3
|
McNally EM, Golbus JR and Puckelwartz MJ:
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin
Invest. 123:19–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flack E and Kannankeril PJ: The genetics
of dilated cardiomyopathy. Heart Rhythm. 9:397–398. 2012.
View Article : Google Scholar
|
|
5
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perrino C and Rockman HA: GATA4 and the
two sides of gene expression reprogramming. Circ Res. 98:715–716.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brody MJ, Cho E, Mysliwiec MR, Kim TG,
Carlson CD, Lee KH and Lee Y: Lrrc10 is a novel cardiac-specific
target gene of Nkx2-5 and GATA4. J Mol Cell Cardiol. 62:237–246.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajagopal SK, Ma Q, Obler D, Shen J,
Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V,
Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB and Pu
WT: Spectrum of heart disease associated with murine and human
GATA4 mutation. J Mol Cell Cardiol. 43:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Fang M, Liu XY, Xin YF, Liu ZM,
Chen XZ, Wang XZ, Fang WY, Liu X and Yang YQ: A novel GATA4
mutation responsible for congenital ventricular septal defects. Int
J Mol Med. 28:557–564. 2011.
|
|
11
|
Liu XY, Wang J, Zheng JH, Bai K, Liu ZM,
Wang XZ, Liu X, Fang WY and Yang YQ: Involvement of a novel GATA4
mutation in atrial septal defects. Int J Mol Med. 28:17–23.
2011.PubMed/NCBI
|
|
12
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang YQ, Li L, Wang J, Liu XY, Chen XZ,
Zhang W, Wang XZ, Jiang JQ, Liu X and Fang WY: A novel GATA4
loss-of-function mutation associated with congenital ventricular
septal defect. Pediatr Cardiol. 33:539–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang YQ, Wang J, Liu XY, Chen XZ, Zhang W,
Wang XZ, Liu X and Fang WY: Novel GATA4 mutations in patients with
congenital ventricular septal defects. Med Sci Monit.
18:CR344–CR350. 2012.PubMed/NCBI
|
|
15
|
Wang E, Sun S, Qiao B, Duan W, Huang G, An
Y, Xu S, Zheng Y, Su Z, Gu X, Jin L and Wang H: Identification of
functional mutations in GATA4 in patients with congenital heart
disease. PLoS One. 8:e621382013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang YQ, Gharibeh L, Li RG, Xin YF, Wang
J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, Liu X, Fang WY, Huang RT,
Xue S and Nemer G: GATA4 loss-of-function mutations underlie
familial tetralogy of Fallot. Hum Mutat. 34:1662–1671. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X,
Xu YJ, Jiang WF, Jiang JQ, Liu X, Fang WY, Zhang M, Peng LY, Qu XK
and Yang YQ: GATA4 loss-of-function mutation underlies familial
dilated cardiomyopathy. Biochem Biophys Res Commun. 439:591–596.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Molkentin JD, Lin Q, Duncan SA and Olson
EN: Requirement of the transcription factor GATA4 for heart tube
formation and ventral morphogenesis. Genes Dev. 11:1061–1072. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuo CT, Morrisey EE, Anandappa R, Sigrist
K, Lu MM, Parmacek MS, Soudais C and Leiden JM: GATA4 transcription
factor is required for ventral morphogenesis and heart tube
formation. Genes Dev. 11:1048–1060. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pu WT, Ishiwata T, Juraszek AL, Ma Q and
Izumo S: GATA4 is a dosage-sensitive regulator of cardiac
morphogenesis. Dev Biol. 275:235–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oka T, Maillet M, Watt AJ, Schwartz RJ,
Aronow BJ, Duncan SA and Molkentin JD: Cardiac-specific deletion of
Gata4 reveals its requirement for hypertrophy, compensation, and
myocyte viability. Circ Res. 98:837–845. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suzuki YJ and Evans TL: Regulation of
cardiac myocyte apoptosis by the GATA-4 transcription factor. Life
Sci. 74:1829–1838. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu X, Zhang L and Liang J: Rosuvastatin
prevents pressure overload-induced myocardial hypertrophy via
inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in
rats. Mol Med Rep. 8:385–392. 2013.PubMed/NCBI
|
|
24
|
Kikuchi K, Holdway JE, Werdich AA,
Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY
and Poss KD: Primary contribution to zebrafish heart regeneration
by gata4(+) cardiomyocytes. Nature. 464:601–605. 2010.PubMed/NCBI
|
|
25
|
Qian L, Huang Y, Spencer CI, Foley A,
Vedantham V, Liu L, Conway SJ, Fu JD and Srivastava D: In vivo
reprogramming of murine cardiac fibroblasts into induced
cardiomyocytes. Nature. 485:593–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song K, Nam YJ, Luo X, Qi X, Tan W, Huang
GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA,
Bassel-Duby R and Olson EN: Heart repair by reprogramming
non-myocytes with cardiac transcription factors. Nature.
485:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lyons I, Parsons LM, Hartley L, Li R,
Andrews JE, Robb L and Harvey RP: Myogenic and morphogenetic
defects in the heart tubes of murine embryos lacking the homeo box
gene Nkx2-5. Genes Dev. 9:1654–1666. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prall OW, Menon MK, Solloway MJ, Watanabe
Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet
H, Stennard FA, Wise N, Schaft D, Wolstein O, Furtado MB, Shiratori
H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham
ME and Harvey RP: An Nkx2-5/Bmp2/Smad1 negative feedback loop
controls heart progenitor specification and proliferation. Cell.
128:947–959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pashmforoush M, Lu JT, Chen H, Amand TS,
Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho
SY, Benson DW, Silberbach M, Shou W and Chien KR: Nkx2-5 pathways
and congenital heart disease; loss of ventricular myocyte lineage
specification leads to progressive cardiomyopathy and complete
heart block. Cell. 117:373–386. 2004.
|
|
30
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reamon-Buettner SM and Borlak J: NKX2-5:
an update on this hypermutable homeodomain protein and its role in
human congenital heart disease (CHD). Hum Mutat. 31:1185–1194.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang J, Xin YF, Liu XY, Liu ZM, Wang XZ
and Yang YQ: A novel NKX2-5 mutation in familial ventricular septal
defect. Int J Mol Med. 27:369–375. 2011.PubMed/NCBI
|
|
33
|
Costa MW, Guo G, Wolstein O, Vale M,
Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M,
Semsarian C, Weintraub RG, Yeoh T, Hayward C, Keogh A, Macdonald P,
Feneley M, Graham RM, Seidman JG, Seidman CE, Rosenthal N, Fatkin D
and Harvey RP: Functional characterization of a novel mutation in
NKX2-5 associated with congenital heart disease and adult-onset
cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elliott P, O’Mahony C, Syrris P, Evans A,
Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and
McKenna WJ: Prevalence of desmosomal protein gene mutations in
patients with dilated cardiomyopathy. Circ Cardiovasc Genet.
3:314–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schlesinger J, Schueler M, Grunert M,
Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I and
Sperling SR: The cardiac transcription network modulated by Gata4,
Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS
Genet. 7:e10013132011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang Q, De Windt LJ, Witt SA, Kimball TR,
Markham BE and Molkentin JD: The transcription factors GATA4 and
GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J
Biol Chem. 276:30245–30253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kirk EP, Sunde M, Costa MW, Rankin SA,
Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, Mackay
JP, Waddell LB, Cole AD, Hayward C, Keogh A, Macdonald P, Griffiths
L, Fatkin D, Sholler GF, Zorn AM, Feneley MP, Winlaw DS and Harvey
RP: Mutations in cardiac T-box factor gene TBX20 are associated
with diverse cardiac pathologies, including defects of septation
and valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
39
|
Yang YQ, Wang MY, Zhang XL, Tan HW, Shi
HF, Jiang WF, Wang XH, Fang WY and Liu X: GATA4 loss-of-function
mutations in familial atrial fibrillation. Clin Chim Acta.
412:1825–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang JQ, Li RG, Wang J, Liu XY, Xu YJ,
Fang WY, Chen XZ, Zhang W, Wang XZ and Yang YQ: Prevalence and
spectrum of GATA5 mutations associated with congenital heart
disease. Int J Cardiol. 165:570–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wei D, Bao H, Liu XY, Zhou N, Wang Q, Li
RG, Xu YJ and Yang YQ: GATA5 loss-of-function mutations underlie
tetralogy of Fallot. Int J Med Sci. 10:34–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei D, Bao H, Zhou N, Zheng GF, Liu XY and
Yang YQ: GATA5 loss-of-function mutation responsible for the
congenital ventriculoseptal defect. Pediatr Cardiol. 34:504–511.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gu JY, Xu JH, Yu H and Yang YQ: Novel
GATA5 loss-of-function mutations underlie familial atrial
fibrillation. Clinics (Sao Paulo). 67:1393–1399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.PubMed/NCBI
|
|
47
|
Kodo K, Nishizawa T, Furutani M, Arai S,
Yamamura E, Joo K, Takahashi T, Matsuoka R and Yamagishi H: GATA6
mutations cause human cardiac outflow tract defects by disrupting
semaphorin-plexin signaling. Proc Natl Acad Sci USA.
106:13933–13938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Maitra M, Koenig SN, Srivastava D and Garg
V: Identification of GATA6 sequence variants in patients with
congenital heart defects. Pediatr Res. 68:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao
H, Yan B, Liu Y, Yang Y and Chen YH: A novel GATA6 mutation in
patients with tetralogy of Fallot or atrial septal defect. J Hum
Genet. 55:662–667. 2010. View Article : Google Scholar
|
|
50
|
Wang J, Luo XJ, Xin YF, Liu Y, Liu ZM,
Wang Q, Li RG, Fang WY, Wang XZ and Yang YQ: Novel GATA6 mutations
associated with congenital ventricular septal defect or tetralogy
of Fallot. DNA Cell Biol. 31:1610–1617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with congenital
ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.PubMed/NCBI
|
|
52
|
Huang RT, Xue S, Xu YJ and Yang YQ:
Somatic mutations in the GATA6 gene underlie sporadic
tetralogy of Fallot. Int J Mol Med. 31:51–58. 2013.
|
|
53
|
Bui PH, Dorrani N, Wong D, Perens G,
Dipple KM and Quintero-Rivera F: First report of a de novo 18q11.2
microdeletion including GATA6 associated with complex congenital
heart disease and renal abnormalities. Am J Med Genet A.
161A:1773–1778. 2013.PubMed/NCBI
|
|
54
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu
YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6
loss-of-function mutation in atrial fibrillation. Eur J Med Genet.
55:520–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
